Whitepaper/App Note

Application Note: Quantitation of intact therapeutic protein in plasma matrix by LC/MS

Posted: 8 January 2019 | | No comments yet

A complete workflow to quantify intact therapeutic proteins in plasma matrix has been developed, covering three critical components in preclinical sample analysis: target protein enrichment/purification, LC/MS data acquisition and quantitative data analysis.

Trastuzumab in rat plasma was enriched/purified with one-hour immuno-capture workflow, to remove background matrix. The enriched/purified intact trastuzumab samples were analysed by high-flow LC/MS in SCIEX X500B QTOF system. A Novel data processing strategy with automated data reconstruction in PeakView® software was utalised to filter out interference from residual matrix proteins. Quantitation of trastuzumab in rat plasma at intact protein level was achieved with a linear dynamic range of 100 ng/mL to 50,000 ng/mL and a limit of detection of 50ng/mL in 50 µL of rat plasma. 

The rest of this content is restricted - login or subscribe free to access

Issue 6 2018 magazine coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here


Send this to a friend